Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Telangiectasia: early-phase trial registry
1 of 3 indexed Telangiectasia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Telangiectasia: 3 US clinical trials tracked, 1 recruiting.
Telangiectasia is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ulthera, running 1 of these trials.
Enrollment posture brief
Registry condition telangiectasia
OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Telangiectasia lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Telangiectasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Telangiectasia is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Cure HHT
NCT06259292
Ultherapy for the Treatment of Spider Veins on the Legs
Ulthera
NCT02286804
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
National Eye Institute (NEI)
NCT00457067
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Telangiectasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Telangiectasia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Telangiectasia page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Telangiectasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ulthera sponsors the most Telangiectasia trials on record, review their full trial history before evaluating a specific study. See Ulthera's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Telangiectasia condition card totals 3 registered trials; most-linked intervention Ultherapy; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.